Who should receive extended infusion beta-lactam therapy?
The increasing prevalence of antibiotic-resistant bacteria challenges a clinician's ability to fight life-threatening infections. Administering beta-lactams via extended infusion may improve patient outcomes. This article discusses the underlying principles of this therapeutic approach and when it may be appropriate.
Journal of the American Academy of Physician Assistants
Roman, Christopher; Solh, Tia; and Damer, Kendra M., "Who should receive extended infusion beta-lactam therapy?" (2016). PCOM Scholarly Papers. 1649.
This document is currently not available here.